» Articles » PMID: 35114769

Clinical Evaluation of 31 Children with Pituitary Insufficiency in the Course of the Pituitary Stalk Interruption Syndrome. The Unexpected Growth Without Growth Hormone in 2 Children

Overview
Publisher Termedia
Specialty Pediatrics
Date 2022 Feb 4
PMID 35114769
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The pituitary stalk interruption syndrome (PSIS) is one of the complex -forms of congenital pituitary insufficiency. Symptoms resulting from insufficiency of the pituitary gland, in spite of the inborn character of the disease, may appear at various stages of life. The aim of this paper was to present clinical presentation in 31 patients with PSIS confirmed radiologically.

Results: In the whole study population during first examination 25.8% children were diagnosed with combined pituitary hormone deficiency (CPHD). During the endocrinological observation (median follow-up 5.1 years, range 0.513.2) of the above-mentioned group 74.2% subjects were diagnosed with CPHD, while 25.8% patients with isolated growth hormone deficiency (GHD). Two children with initially short stature were confirmed with GHD. As a result of the parents' decision, growth hormone therapy was either not started or discontinued. During further follow-up, however, the children achieved normal height.

Conclusions: Children with PSIS present a diverse clinical picture and should be observed because of the risk of further pituitary disorders. In the differential diagnosis of hypoglycemia in the neonatal period and in infancy, hypopituitarism should be considered. The phenomenon of normal growth in patients with confirmed growth hormone deficiency has been observed, although is not fully understood.

Citing Articles

Pituitary stalk interruption syndrome and liver cirrhosis associated with diabetes and an inactivating gene mutation: a case report and literature review.

Liu Z, Zhao W, Cao C, Wang Y, Xiao L, Wang X Front Endocrinol (Lausanne). 2023; 14:1297146.

PMID: 38152125 PMC: 10751576. DOI: 10.3389/fendo.2023.1297146.


Comparison of clinical characteristics of a pediatric cohort with combined pituitary hormone deficiency caused by mutation of the PROP1 gene or of other origins.

Zygmunt-Gorska A, Wojcik M, Gilis-Januszewska A, Starmach A, Bik-Multanowski M, Starzyk J Hormones (Athens). 2023; 23(1):69-79.

PMID: 38147295 PMC: 10847174. DOI: 10.1007/s42000-023-00510-1.


Delayed Diagnosis of Congenital Combined Pituitary Hormone Deficiency including Severe Growth Hormone Deficiency in Children with Persistent Neonatal Hypoglycemia-Case Reports and Review.

Smyczynska J, Pawelak N, Hilczer M, Lewinski A Int J Mol Sci. 2022; 23(19).

PMID: 36232371 PMC: 9570002. DOI: 10.3390/ijms231911069.

References
1.
El Chehadeh S, Bensignor C, de Monleon J, Mejean N, Huet F . The pituitary stalk interruption syndrome: endocrine features and benefits of growth hormone therapy. Ann Endocrinol (Paris). 2010; 71(2):102-10. DOI: 10.1016/j.ando.2009.11.007. View

2.
Brauner R, Bignon-Topalovic J, Bashamboo A, McElreavey K . Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. PLoS One. 2020; 15(12):e0242358. PMC: 7714207. DOI: 10.1371/journal.pone.0242358. View

3.
Voutetakis A, Sertedaki A, Dacou-Voutetakis C . Pituitary stalk interruption syndrome: cause, clinical manifestations, diagnosis, and management. Curr Opin Pediatr. 2016; 28(4):545-50. DOI: 10.1097/MOP.0000000000000378. View

4.
Castinetti F, Reynaud R, Quentien M, Jullien N, Marquant E, Rochette C . Combined pituitary hormone deficiency: current and future status. J Endocrinol Invest. 2014; 38(1):1-12. DOI: 10.1007/s40618-014-0141-2. View

5.
Giordano M . Genetic causes of isolated and combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab. 2016; 30(6):679-691. DOI: 10.1016/j.beem.2016.09.005. View